openPR Logo
Press release

Diabetes Devices and Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast

06-14-2017 02:40 PM CET | Industry, Real Estate & Construction

Press release from: Industry Research Reports - MRRSE

MRRSE

MRRSE

Diabetes is a chronic metabolic disease wherein the body is either not able to produce insulin (type-1) or is not able to utilize the generated insulin (type-2). This elevated sugar level leads to various symptoms such as increased thirst, weight loss, and high appetite, frequent and sweet smelled urination. If untreated, diabetes causes various acute and chronic life-threatening complications. This report studies the current as well as future scenario of the diabetes diagnostic devices and drugs market globally.

Request for Sample Report: www.mrrse.com/sample/931

The Diabetes Diagnostic Devices and drugs market has been segmented based on devices and drugs available for the treatment the disease. Based on device type, the market is segmented into diabetes diagnostic devices and insulin delivery devices. Diabetes diagnostic devices include analog blood meter, test strips, lancets and lancing devices, continuous glucose monitoring devices and others. The insulin delivery devices segment include insulin syringes, insulin pens, insulin pumps and insulin injectors.

Based on drugs, the market is segmented into insulin derivatives, oral anti-diabetes drugs and non-insulin injectable anti-diabetes drugs. The insulin derivatives segment is further categorized as rapid-acting, short-acting, intermediate-acting, long-acting and premixed insulin derivatives. The oral anti-diabetes drugs segment includes various drugs classes such as sulphonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors, GPP-4 inhibitors and SGLT-2 inhibitors. The non-insulin injectable anti-diabetes drugs segment is segmented into GLP-1 analogs and Pramlintide. The market for these devices and drugs has been extensively analyzed based on demand for branded and generic products in each class of drugs and devices. Rising prevalence of diabetic population across various regions of the world, pipeline products from each class, rising preference of patients and healthcare professionals toward technologically advanced monitoring and insulin delivery devices is driving the growth of the diabetes diagnostic devices and drugs market.

Make an Enquiry: www.mrrse.com/enquiry/931

The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The diabetes devices and drugs market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019.

Geographically, the diabetes diagnostic devices and drugs market has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each region has been provided for the period 2011 to 2019, along with the CAGR (%) for the forecast period 2013 to 2019. The diabetes diagnostic devices and drugs market study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises a qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five forces analysis and market attractiveness analysis. In addition, thorough analyses of various events, which occurred in the past five years and are expected to occur during forecast period, are also provided in the market overview section of the report. In this section, the major events, which affected the market and are expected to affect the market are studied. Further, value chain analysis (VCA) for drugs and devices is also provided, which highlights the major stages of the development of drugs and devices. The entire section of market overview plays an important role in understanding the market on a global level.

The diabetes devices and drugs market report also provides a highlight of the competitive landscape of the market wherein the market share analysis of the leading players in the diabetes devices and drugs market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the diabetes devices and drugs market such as Abbott Laboratories, Inc., AstraZeneca plc, B Braun Melsungen AG, Bayer HealthCare AG, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, DexCom, Inc., Eli Lilly and Company, F. Hoffmann La-Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Lupin Limited, Medtronic, Inc., Merck & Co., Inc., Novartis International AG, Novo Nordisk A/S, Sanofi, and Takeda Pharmaceutical Company Limited. Market players are profiled based on attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

Browse Full Report with TOC: www.mrrse.com/diabetes-devices-market

About Us

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Follow Us on LinkedIn-www.linkedin.com/company/mrrse
Follow Us On Twitter-twitter.com/MRRSEmrrse

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetes Devices and Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast here

News-ID: 578215 • Views: 229

More Releases from Industry Research Reports - MRRSE

ECG Systems Industry- Global Market Analysis, Size, Share, Growth, Trends, and F …
Recently, the medical diagnostic sector for electrocardiogram (ECG) which detects heart problems has seen a surge in business, due to the global rise in lifestyle disorders like diabetes and obesity. This test investigates the real cause for anginas, chest pains, heart attacks, symptoms of heart diseases, and even issues with pacemakers, high blood pressure and early heart diseases. A new study is added to the vast repository of Market Research
Global Market Study on Enterprise Governance, Risk and Compliance (EGRC)-MRRSE
Enterprise governance, risk and compliance (EGRC) being a multifaceted and innovative approach to risk management, corporate governance and compliance issues has a direct impact on business objectives. Market Research Reports Search Engine (MRRSE) has recently publicized the addition of a new research report to its vast online repository with a title “Enterprise Governance, Risk and Compliance (EGRC) Market: Global Industry Analysis and Forecast, 2016-2024”. This report on global enterprise governance, risk and
Global Market Study on Cable Cars & Ropeways :Growing Preference for Elevators a …
 With a rise in global GDP, disposable income of people has also increased. People are now capable of spending a significant share of their earnings in amusement and leisure activities. Considering this scenario, Market Research Reports Search Engine (MRRSE) has recently publicized the addition of a new market report to its vast online repository with a title “Cable Cars and Ropeways Market: Global Industry Analysis and Forecast, 2016-2024”. This report
Metal Oxide Varistor (MOV) Market - Global Industry Analysis, Size, Share, Growt …
The global market for metal oxide varistor (MOV) is deriving much of its growth from the rising popularity of Internet of Things (IoT) and the upsurge in its adoption in automobile applications. A new research report titled as “Metal Oxide Varistor (MOV) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025” has been recently added to the huge portfolio of Market Research Reports Search Engine (MRRSE) online

All 144 Releases


More Releases for Diabetes

Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
27th European Diabetes Congress
Rising awareness, new technologies and practical approaches within the field of diabetes and endocrine disorders in world’s leading diabetes Conferences One in eight ladies can develop a diabetes disorder throughout her lifespan. And, the amount of individuals affected by diabetes disorders continues to rise every year. However the larger drawback is that almost 60 minutes of those individuals are fully unaware of their condition as well as a way to heal
27th European Diabetes Congress
We would like to invite your team as a Speakers/Delegates. On behalf of Organizing Committee, we take this opportunity in extending a warm and cordial welcome to you to be part of “27th European Diabetes Congress”, held conjointly with multifarious scientific associations, eminent researchers and scholars from all around the globe during June 20-21, 2018 at Rome, Italy. It is an immense pleasure and privilege having you here with us
Diabetes Gastroparesis Market grows with rising prevalence of diabetes
Diabetes type 1 and type 2 are one of the most common chronic diseases prevalent in the world, affecting millions of people. One of the disorders associated with diabetes type 1 and type 2 is gastroparesis, which is characterized by the delayed emptying of the stomach. One of the major causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the
18th European Diabetes Congress
It takes us immense pleasure to announce the conference that 18th European Diabetes Congress which is going to be held during July 17-18, 2017 at Lisbon, Portugal. Euro Diabetes 2017 conference will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Diabetes
SOLUTIONS TO CHILDHOOD DIABETES
Chef Gayle Gaggero is worried. Gaggero, CEO of Kids Culinary Adventures (KCA), has read the reports from the Centers for Disease Control indicating the dramatic rise of Type II Diabetes in children. This rise has been directly linked to the increase in childhood obesity. Gaggero asserts that childhood obesity rates are tantamount to a brewing epidemic. Children, and some parents for that matter, do not know how to